Contact Us Japanese Chinese Font size A A About NAGASE News Business Introduction Investor Relations Sustainability HOMENews Release:2016 Newsrelease:2016 Disclosure December 22, 2016 FYE March 2017 Second Quarter Financial Briefing(pdf:2 MB) Disclosure November 25, 2016 FYE March 2017 Second Quarter Financial Highlights(pdf:270 KB) Disclosure November 25, 2016 Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2017(pdf:251 KB) Disclosure September 21, 2016 Notice Concerning Completion of Repurchase of Own Shares and Results of Repurchase of Own Shares through Off-Auction Own Share Repurchase Trading(ToSTNeT-3)(pdf:88 KB) Disclosure September 21, 2016 Notice Concerning Repurchase of Own Shares through Off-Auction Own Share Repurchase Trading(ToSTNeT-3)(pdf:87 KB) Disclosure August 26, 2016 FYE March 2017 First Quarter Financial Highlights(pdf:282 KB) Disclosure August 26, 2016 Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2017(pdf:223 KB) Info June 27, 2016 U.S. FDA issues GRAS “No Questions Letter” for Isomaltodextrin Disclosure June 15, 2016 FYE March 2016 Financial Briefing Supplemental Data(pdf:397 KB) Disclosure June 15, 2016 FYE March 2016 Financial Briefing(pdf:3 MB) News June 13, 2016 Nagase Medicals will strengthen the production capabilities for high potency injection drug(pdf:169 KB) Disclosure June 02, 2016 Renewal of Policy for Responding to Large-Scale Purchases of the Company Shares (Anti-Takeover Measures)(pdf:377 KB) IR June 02, 2016 2016 Annual General Shareholders’ Meeting Disclosure May 27, 2016 Consolidated Financial Statements for the Fiscal Year Ended March 31, 2016(pdf:552 KB) Disclosure May 27, 2016 FYE March 2016 Financial Highlights(pdf:361 KB) Disclosure May 27, 2016 Mid‐term Management Plan ACE‐2020(pdf:657 KB) Info March 01, 2016 Launch of NAGASE branding project Disclosure February 22, 2016 FYE March 2016 Third Quarter Financial Highlights(pdf:231 KB) Disclosure February 22, 2016 Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2016(pdf:129 KB) Info February 01, 2016 【Nagase (Thailand)Co. Ltd. Yangon Branch】 Operating Information 1 2 次へ » News 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 About NAGASE Basic Principle CEO Message Management Policy and Plan Corporate Profile Organization Board of Directors & Executive Officers NAGASE Group News 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Business Introduction Performance Chemicals Department Speciality Chemicals Department Colors & Advanced Processing Department Polymer Global Account Department Electronics Department Functional Resin Department Precision Process Materials Department Information & Communication ・ Energy Office Mobility Solutions Department Life & Healthcare Products Department Food Ingredients Department Nagase R&D Center Nagase Application Workshop New Value Creation Office NAGASE Biotech Office Investor Relations IR News:2021 Individual Investors Financial Information Investor Relations Library Shareholder Information Sustainability Sustainability in the NAGASE Group Governance Innovation Human Rights and Work Environment Customers / Supply Chain Social Contributions Environment Athlete Support Sustainability Data Sheet History of NAGASE Corporate Movie Important Information Nagase’s Personal Data Protection Policy Regarding Handling of Personal Data Privacy Policy of this Website Caution before use Contact Us Sitemap Social Media Policy Unauthorized copying of any contents including ad illustrations is prohibited. Copyright ©2021 NAGASE & CO., LTD. All rights reserved.